Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Halperin

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Scandinavian Journal of Infectious Diseases|January 1, 1995
Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants 2-6 months oldS A Halperin, B Eastwood, L Barreto, et al.
The Pediatric Infectious Disease Journal|April 27, 2000
Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adultsS A Halperin, B Smith, M Russell, et al.
Infection and Immunity|May 24, 2005
Infection of newborn piglets with Bordetella pertussis: a new model for pertussisS Elahi, R Brownlie, J Korzeniowski, et al.
Journal of Clinical Microbiology|March 1, 1994
Identification of Bordetella pertussis infection by shared-primer PCRZ Li, D L Jansen, T M Finn, et al.
Clinical and Experimental Immunology|June 1, 2006
Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussisJ B Knight, Y Y Huang, S A Halperin, et al.
Vaccine|December 12, 2018
Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trialA Cattapan, K Browne, D M Halperin, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 29, 2011
Immunogenicity of a half-dose of adjuvanted 2009 pandemic H1N1 influenza vaccine in adults: a prospective cohort studyB L Coleman, S P Kuster, J Gubbay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 18, 1999
Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program--Active (IMPACT)S A Halperin, E E Wang, B Law, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|May 18, 2018
Canadian vaccine research networks: Vaccine safety resources for CanadaJ McCarthy, S A Halperin, J A Bettinger, et al.
Vaccine|June 16, 2016
Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: A Canadian Immunization Research Network studyJ M Langley, D M MacDougall, B A Halperin, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Scandinavian Journal of Infectious Diseases|January 1, 1995
Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants 2-6 months oldS A Halperin, B Eastwood, L Barreto, et al.
The Pediatric Infectious Disease Journal|April 27, 2000
Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adultsS A Halperin, B Smith, M Russell, et al.
Infection and Immunity|May 24, 2005
Infection of newborn piglets with Bordetella pertussis: a new model for pertussisS Elahi, R Brownlie, J Korzeniowski, et al.
Journal of Clinical Microbiology|March 1, 1994
Identification of Bordetella pertussis infection by shared-primer PCRZ Li, D L Jansen, T M Finn, et al.
Clinical and Experimental Immunology|June 1, 2006
Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussisJ B Knight, Y Y Huang, S A Halperin, et al.
Vaccine|December 12, 2018
Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trialA Cattapan, K Browne, D M Halperin, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 29, 2011
Immunogenicity of a half-dose of adjuvanted 2009 pandemic H1N1 influenza vaccine in adults: a prospective cohort studyB L Coleman, S P Kuster, J Gubbay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 18, 1999
Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program--Active (IMPACT)S A Halperin, E E Wang, B Law, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|May 18, 2018
Canadian vaccine research networks: Vaccine safety resources for CanadaJ McCarthy, S A Halperin, J A Bettinger, et al.
Vaccine|June 16, 2016
Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: A Canadian Immunization Research Network studyJ M Langley, D M MacDougall, B A Halperin, et al.
Pageof 10